VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > The other side of 74.5%

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Apr 25, 2023 6:57pm

61 Views

Post# 35413523

RE:RE:RE:RE:RE:The other side of 74.5%

GrahamB ... Nice try. In your case, FUD = Fear, Uncertainty, Doubt.

No doubt.

Living in the past is not useful. Sales will happen, in due timeas because this technology answers a real need. Top-tier hospitals. Even GEHC has assess that this technology fits their Edison platform.

You're just playing on the time factor. FUD.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in